Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness

Last updated: March 18, 2026
Sponsor: Chinese University of Hong Kong
Overall Status: Active - Recruiting

Phase

N/A

Condition

Depression

Treatment

Dim red light

Bright light therapy

Clinical Study ID

NCT06973759
2024.494-T
12230316
  • Ages 12-19
  • All Genders

Study Summary

This study examines the efficacy of bright light therapy as a treatment for adolescents diagnosed with unipolar non-seasonal depression who exhibit an evening chronotype.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Chinese, aged 12-19 years old;

  2. Written informed assent/consent of participation into the study is given by theparticipant and his/her parent or guardian (for those aged under 18), respectively;

  3. Having a DSM-5 diagnosis of unipolar non-seasonal depression as confirmed by theChinese version of the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS) psychiatric interview, DSM-5 Seasonal specifier, AND having a score onChildren's Depression Rating Scale (CDRS-R) at least 40;

  4. Being classified as evening chronotype according to the score on the reducedHorne-Östberg Morning-Eveningness Questionnaire (rMEQ), i.e. <12.

Exclusion

Exclusion Criteria:

  1. A current diagnosis of substance abuse or dependence; a current or past history ofmanic or hypomanic episode, schizophrenia spectrum disorders, organic mentaldisorders, or intellectual disabilities;

  2. Having a clinically significant suicidality (presence of suicidal ideation with aplan or an attempt) as assessed by K-SADS;

  3. Having been enrolled in any other clinical trial investigational products within onemonth at the entry of the study;

  4. Initiation of or change in antidepressant medication within past 4 weeks;

  5. Having been or is currently receiving any structured psychotherapy;

  6. With hearing or speech deficit;

  7. Night shift worker;

  8. Trans-meridian flight across at least two time zones in the past 3 months and duringthe study;

  9. Presence of an eye disease, e.g., retinal blindness, severe cataract, glaucoma.

Study Design

Total Participants: 90
Treatment Group(s): 2
Primary Treatment: Dim red light
Phase:
Study Start date:
November 01, 2025
Estimated Completion Date:
June 30, 2028

Study Description

This randomized, placebo-controlled, assessor-blinded trial aims to evaluate the efficacy of bright light therapy (BLT) as a treatment for adolescents with depression and evening chronotype. Eligible participants will be randomized to receive either BLT or dim red light (placebo) daily for 8 weeks. Depression severity, sleep parameters, and circadian markers will be assessed at baseline, during treatment, post-treatment, and at follow-up visits.

Connect with a study center

  • The Chinese University of Hong Kong

    Hong Kong, Hong Kong 999077
    Hong Kong

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.